Overview

A Positron Emission Tomography (PET) Study to Examine the Brain Binding Properties of a Novel Radioactive Compound [11C]-PXT012253 in Healthy Subjects

Status:
Completed
Trial end date:
2019-03-15
Target enrollment:
Participant gender:
Summary
This study evaluates the usefulness of a PET radioligand to estimate the binding on the mGlu4 receptor in the brain. mGlu4 has been proposed as a therapeutic target in Parkinson's disease.
Phase:
Early Phase 1
Details
Lead Sponsor:
H. Lundbeck A/S